The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, but its future within the broader market now raises questions about potential yields . Alternative versions are undercutting patent protection , prompting concerns that supporting companies heavily reliant to Viagra's once-dominant influence could be